Edmund Harrigan
Director, Acadia Pharmaceuticals.
Companies
- IncyteBoard member Dec 19, 2019 to now1
- Acadia PharmaceuticalsBoard member Nov 30, 2015 to now2
- PhaseBio Pharmaceuticals IncBoard member Dec 17, 2018 to May 19, 20233
- Karuna TherapeuticsBoard member Jun 27, 2019 to Aug 14, 20204
- BELLICUM PHARMACEUTICALS, INCBoard member Feb 22, 2018 to Jun 14, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Incyte INCY23,019 shares6$2.6M at $113.77Jun 30, 2026- Acadia Pharmaceuticals ACAD43,148 shares7$846.1K at $19.61May 29, 2026
- PhaseBio Pharmaceuticals Inc9,750 shares8May 19, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Granted 255 shares at $113.36 of Incyte6
- Jun 8, 2026Granted 1,642 shares of Incyte9
- May 29, 2026Exercised options 8,107 shares of Acadia Pharmaceuticals7
- Mar 31, 2026Granted 269 shares at $94.12 of Incyte10
- Dec 31, 2025Granted 245 shares at $98.77 of Incyte11
- Sep 30, 2025Granted 289 shares at $84.81 of Incyte12
- Jun 30, 2025Granted 367 shares at $68.10 of Incyte13
- Jun 10, 2025Granted 2,518 shares of Incyte14
- May 29, 2025Exercised options 9,387 shares of Acadia Pharmaceuticals15
- Mar 31, 2025Granted 363 shares at $60.55 of Incyte16
- Dec 31, 2024Granted 339 shares at $69.07 of Incyte17
- Sep 30, 2024Granted 378 shares at $66.10 of Incyte18
- Jun 28, 2024Granted 409 shares at $60.62 of Incyte19
- Jun 12, 2024Granted 2,830 shares of Incyte20
- May 29, 2024Exercised options 6,652 shares of Acadia Pharmaceuticals21
- Mar 28, 2024Granted 413 shares at $56.97 of Incyte22
- Dec 29, 2023Granted 423 shares at $62.79 of Incyte23
- Sep 29, 2023Granted 389 shares at $57.77 of Incyte24
- Jun 30, 2023Granted 390 shares at $62.25 of Incyte25
- Jun 14, 2023Granted 2,505 shares of Incyte26
- Jun 1, 2023Exercised options 8,552 shares of Acadia Pharmaceuticals27
- May 19, 2023Exercised options 3,750 shares of PhaseBio Pharmaceuticals Inc8
- Mar 31, 2023Granted 326 shares at $72.27 of Incyte28
- Dec 30, 2022Granted 302 shares at $80.32 of Incyte29
- Oct 19, 2022Granted 165 shares at $69.59 of Incyte30
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIncyte, Board member
- 2SEC EDGARAcadia Pharmaceuticals, Board member
- 3
- 4SEC EDGARKaruna Therapeutics, Board member
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 10, 2026
- 10SEC EDGARForm 4 filed Apr 2, 2026
- 11SEC EDGARForm 4 filed Jan 5, 2026
- 12SEC EDGARForm 4 filed Oct 2, 2025
- 13SEC EDGARForm 4 filed Jul 2, 2025
- 14SEC EDGARForm 4 filed Jun 12, 2025
- 15SEC EDGARForm 4 filed Jun 2, 2025
- 16SEC EDGARForm 4 filed Apr 2, 2025
- 17SEC EDGARForm 4 filed Jan 3, 2025
- 18SEC EDGARForm 4 filed Oct 2, 2024
- 19SEC EDGARForm 4 filed Jul 2, 2024
- 20SEC EDGARForm 4 filed Jun 14, 2024
- 21SEC EDGARForm 4 filed May 31, 2024
- 22SEC EDGARForm 4 filed Apr 2, 2024
- 23SEC EDGARForm 4 filed Jan 3, 2024
- 24SEC EDGARForm 4 filed Oct 3, 2023
- 25SEC EDGARForm 4 filed Jul 5, 2023
- 26SEC EDGARForm 4 filed Jun 16, 2023
- 27SEC EDGARForm 4 filed Jun 5, 2023
- 28SEC EDGARForm 4 filed Apr 4, 2023
- 29SEC EDGARForm 4 filed Jan 4, 2023
- 30SEC EDGARForm 4 filed Oct 20, 2022